See also this year's filing and all EDGAR filings for this company.
PDF Report 0001806952_2026_Lyell_Immunopharma_Inc.pdf
Logs
Graph
Absolute values for 0001806952, Lyell Immunopharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 260,939,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 34,771,000 |
| 3 | remainder_Assets | 44,342,000 |
| 4 | LiabilitiesCurrent | 49,412,000 |
| 5 | LiabilitiesNoncurrent | 42,438,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 43,723,395 |
| 9 | ResearchAndDevelopmentExpense | 221,298,357 |
| 10 | remainder_Expenses | 37,444,541 |
| 11 | remainder_Revenues | 43,612 |
| 12 | remainder_NetIncome | 759,726 |
| 13 | remainder_ComprehensiveNetIncome | 114,216 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 340,052,000 |
| 1 | Liabilities | 91,850,000 |
| 2 | Expenses | 302,466,293 |
| 3 | Revenues | 43,612 |
| 4 | StockholdersEquity | 248,202,000 |
| 5 | NetIncome | -301,662,955 |
| 6 | ComprehensiveNetIncome | -301,605,847 |
| 7 | BaseVar | 367,642,924 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.11 |
| 9 | EconomicCapitalRatio | 2.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
